Internal Medicine, Endocrinology, Diabetes, & Metabolism · Myrtle Beach, SC
NPI
1407053879
Since 2007
Specialty
Internal Medicine, Endocrinology, Diabetes, & Metabolism
Code 207RE0101X
Group practices
2
Medicare group memberships
Hospitals
4
Hospital affiliations
945 82nd Pkwy
Myrtle Beach, SC, 29572
Phone (843) 497-5929
Groups this clinician bills Medicare through
Medicare paid, 2024
$86K
1,209 services
Medicare patients, 2024
570
Average age 73
Drug cost, 2024
$795K
1,827 prescriptions
Company payments, 2025
$91K
From 19 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Gauri Dhir was code 99214 (office e&m - established), 406 times for 331 patients. In total Gauri Dhir billed 1,209 services in 16 codes, and Medicare paid $86K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2025-02-18.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 406 | 331 | $83.24 | $34K |
| 36415 Venipuncture Blood Collection | Office | 288 | 219 | $8.65 | $2,491 |
| 99215 Office E&M - Established | Office | 207 | 160 | $113.57 | $24K |
| 99204 Office E&M - New | Office | 87 | 87 | $105.41 | $9,171 |
| 99205 Office E&M - New | Office | 85 | 85 | $142.40 | $12K |
| 95251 Test - Miscellaneous | Office | 42 | 28 | $24.75 | $1,039 |
| 83036 Blood Count | Office | 38 | 33 | $9.30 | $353 |
| 10005 Other Organ Systems | Office | 21 | 21 | $92.11 | $1,934 |
By year: 2022 $85K for 1,282 services; 2023 $94K for 1,318 services; 2024 $86K for 1,209 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 288 | 219 | $8.65 | $2,491 |
| 83036 Blood Count | 38 | 33 | $9.30 | $353 |
Medicare prescription drug claims, 2024
In 2024, the drug Gauri Dhir prescribed most often to Medicare patients was Levothyroxine Sodium, with 483 prescriptions and refills. In total Gauri Dhir wrote 1,827 Medicare prescriptions that cost $795K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Levothyroxine Sodium Generic | 483 | 1,327 | 172 | $7,938 |
| Ozempic Semaglutide | 157 | 325 | 55 | $310K |
| Methimazole Generic | 121 | 337 | 41 | $1,317 |
| Synthroid Levothyroxine Sodium | 102 | 252 | 35 | $9,831 |
| Metformin Hcl Generic | 68 | 198 | 27 | $630 |
| Jardiance Empagliflozin | 52 | 100 | Under 11 | $57K |
| Mounjaro Tirzepatide | 49 | 78 | 13 | $82K |
| Nano 2nd Gen Pen Needle Pen Needle, Diabetic | 43 | 108 | 17 | $4,514 |
| Hydrocortisone Generic | 41 | 83 | 15 | $2,492 |
| Tirosint Levothyroxine Sodium | 39 | 89 | 12 | $12K |
| Alendronate Sodium Generic | 39 | 88 | 14 | $412 |
| Tresiba Flextouch U-100 Insulin Degludec | 36 | 81 | 14 | $31K |
| Lantus Solostar Insulin Glargine,hum.Rec.Anlog | 34 | 103 | 16 | $4,818 |
| Euthyrox Levothyroxine Sodium | 32 | 96 | 14 | $360 |
| Lyumjev Kwikpen U-100 Insulin Lispro-Aabc | 30 | 75 | 14 | $29K |
Brand drugs: 950 claims; generic drugs: 770 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Gauri Dhir $91K ($91K in general payments such as food, travel and fees) from 19 companies. The largest payer was Novo Nordisk Inc with $78K.
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc NVO | 62 | $78K |
| Dexcom, Inc. DXCM | 15 | $12K |
| Amgen Inc. AMGN | 20 | $406 |
| UCB, Inc. UCB.BR | 8 | $169 |
| Radius Health, Inc. | 6 | $108 |
| Boston Scientific Corporation BSX | 1 | $104 |
| Abbott Laboratories ABT | 5 | $85.35 |
| Novartis Pharmaceuticals Corporation NVS | 4 | $62.24 |
| Recordati_rare_diseases_inc. | 2 | $57.37 |
| Madrigal Pharmaceuticals MDGL | 1 | $44.28 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.